Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TESS: Total Neoadjuvant Treatment for Rectal Cancer
NCT03840239Phase 2Active, not recruiting
- Sponsor
- Sun Yat-sen University
- Start
- Dec 2018
- Primary completion
- Dec 2023
- Modality
- DNA Intercalators/Alkylators
- Countries
- 1
01
Overview
A Phase 2 trial of oxaliplatin in rectal cancer, sponsored by Sun Yat-sen University. Started Dec 2018; status: active, not recruiting.
02
Drugs
oxaliplatin
03
Conditions
rectal cancer
Beyond the preview
Go deeper on NCT03840239.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03840239.